Source: Annual Congress 2001 - Asthma and interstitial lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ulubas, F. Cimen, T. Eryilmaz, S. Alpar, M. Calioglu (Mersin, Ankara, Turkey). Lipid profiles with COPD patients. Eur Respir J 2001; 16: Suppl. 31, 2963

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory markers and lipid profile in COPD patients over nine years Source: International Congress 2017 – COPD biomarkers Year: 2017 Lipid profile in current smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 161s Year: 2006 Nutritional status and lipid parameters in COPD patients Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Features of carbohydrate metabolism in patients with COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Carbohydrate metabolism state in COPD patients Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Lipid profile changes in asthma patients at acute attack and stable period Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Characterization of patients with severe COPD Source: International Congress 2018 – COPD around the world Year: 2018 Microparticles in stable and exacerbated COPD patients Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Impact of the phosphatidylcholine treatment program on the surfactant protein D levels in hypertensive patients with Acute Exacerbations of COPD Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Protein oxidation in the diaphragm of patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 358s Year: 2003 Characterising symptom ‘trajectotypes’ in patients with COPD Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006 Acute phase markers in elderly patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004